Replay available

Corvus Pharmaceuticals, Inc. (CRVS) Q4 2024 Earnings Call

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) Q4 2024 earnings conference call, held 2025-03-25. Replay captured from the company's public earnings webcast.

Tue, March 25, 2025 at 4:30 PMendedReplay
Corvus Pharmaceuticals, Inc. (CRVS) Q4 2024 Earnings Call

Hosted by

Featured presenters

Leif Lee

Chief Financial Officer

Richard Miller

Chief Executive Officer

Jeff Jones

Analyst, Oppenheimer

Aiden Hoseinoff

Analyst, Leidenberg Timeline

Unidentified Speaker

Unknown

Greg Sivanave

Analyst, Mizuho Securities

Roger Song

Analyst, Jeffries

Lee Watzek

Analyst, Cantor

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Corvus Pharmaceuticals, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.614 Good afternoon, everyone. Thank you for standing by. 00:00:02.614 -- 00:00:07.820 And welcome to the Corvus Pharmaceuticals 4th Quarter and Full Year 2024 Business 00:00:07.820 -- 00:00:11.464 Update and Financial Results Conference Call. 00:00:11.464 -- 00:00:14.728 At this time, all participants are in a listen-only mode. 00:00:14.728 -- 00:00:19.193 Later, we will conduct a question-and-answer session, and instructions will follow at 00:00:19.193 -- 00:00:22.416 that time. It is now my pleasure to turn the call over to Mr. 00:00:22.416 -- 00:00:27.520 Zach Kubo of Friel Chemistry. Thank you. Please go ahead, sir. 00:00:27.605 -- 00:00:30.068 Thank you, Operator, and good afternoon, everyone. 00:00:30.068 -- 00:00:35.716 Thanks for joining us for the Corvus Pharmaceuticals' fourth quarter and full year 2024 00:00:35.716 -- 00:00:39.160 Business Update and Financial Results Conference Call. 00:00:39.160 -- 00:00:43.265 On the call to discuss the results and business updates are Richard Miller, Chief Executive 00:00:43.265 -- 00:00:48.652 Officer, Leif Lee, Chief Financial Officer, Jeff Arcarra, Chief Business Officer, 00:00:48.652 -- 00:00:53.812 and Ben Jones, Senior Vice President of Regulatory and Pharmaceutical Sciences. 00:00:53.812 -- 00:00:57.658 The executive team will open the call with some prepared remarks followed by a question 00:00:57.658 -- 00:00:59.461 and answer period. 00:00:59.461 -- 00:01:03.027 I would like to remind everyone that comments made by management today and answers to 00:01:03.027 -- 00:01:05.892 questions will include forward-looking statements. 00:01:05.892 -- 00:01:09.858 Forward-looking statements are based on estimates and assumptions as of today and are 00:01:09.858 -- 00:01:14.265 subject to ...